Charles Loprinzi on Chemotherapy-Induced Peripheral Neuropathy

Charles Loprinzi, MD, Mayo Clinic, discusses managing chemotherapy-induced peripheral neuropathy in adult patients with cancer.

When patients present with symptoms of chemotherapy-induced neuropathy, healthcare professionals need to weigh the benefits of continuing therapy.

Loprinzi says that he tends to stop treatment early in patients with neuropathy in order to prevent the condition from becoming chronic.